| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Reduced Haloperidol |
|---|
| Description | An active metabolite of haloperidol; formed via reduction of haloperidol by ketone reductase; inhibits radioligand binding to sigma-1 and dopamine D2 receptors (Kis = 1.4 and 31 nM, respectively); stimulates BDNF secretion from CCF-SSTG1 and U87MG astrocytic glial cells; inhibits norepinephrine, dopamine, and 5-HT reuptake (Kis = 21, 25, and 33 μM, respectively, in COS-7 cells expressing the human transporters); increases latency to paw withdrawal in mouse models of capsaicin-induced mechanical hypersensitivity at 0.5 mg/kg |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Haloperidol Metabolite II |
|---|
| Gene, Accession, CAS # | CAS: 34104-67-1 |
|---|
| Catalog # | 28017-5 |
|---|
| Price | |
|---|
| Order / More Info | Reduced Haloperidol from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|